In addition, MG-ADL is subject to high floor effects and it is possible that patients with MG-associated symptoms exist in the group with 0p.38 Lastly, we have not been able to take into account prescribed treatments for the calculated outcomes, such as doses of choline esterase inhibitors or immunomodulatory agents. Here, BCHE is linked to myasthenia gravis.